A Phase 2 interventional study of exosomes in androgenetic alopecia
Not Yet Recruiting Phase 1 NCT06482541
Study Description
Testing the safety and effectiveness of exosome microneedling for hair loss
Study Details
- Registry ID:
- NCT06482541
- Conditions:
- Androgenetic Alopecia
- Phase:
- Phase 1
- Target Enrollment:
- 100 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Levit Dermatology
Brooklyn, New York, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.